NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1205364502 M.D.
Verify on CMS → Sarah Kanbour, M.D.
Endocrinology, Diabetes & Metabolism Physician in Boston, Massachusetts.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,078 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
20
Medicare Part D claims · 12 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
0%
generic claims · 95% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Sarah Kanbour, M.D. filed 20 Medicare Part D claims in 2024 as an Endocrinology, Diabetes & Metabolism Physician in Boston, Massachusetts, prescribing 0% generic.
- 20
- Part D claims, 2024
- 0%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥0th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Sarah Kanbour, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1205364502), first enumerated 05/31/2017.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 20 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- State context
State board disciplinary context
Massachusetts statewide board action statistics are published annually — these figures describe aggregate state activity, not Sarah Kanbour, M.D.'s individual license status. Verify directly with the state medical board.
Source: BORIM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1205364502 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-RECENT · TAX-MID · RX-TRACE · BOOK-THIN · PHOTO-ENUM
- NPI-10 1205364502
- ENUM-RECENT 2017
- TAX-MID 8K Endocrinology, Diabetes
- RX-TRACE 20
- BOOK-THIN 373 in Massachusetts
- PHOTO-ENUM Kyaw Zin Win · 2017
Sarah Kanbour, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
20 ≥ 0th percentile 0% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Sarah Kanbour, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Sarah Kanbour, M.D.?
Quality data not reportedPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
20 99% vs specialty avg
Specialty distribution in Massachusetts
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Massachusetts providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1205364502 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 05/31/2017 |
Hospital and facility affiliations
Facilities where Sarah Kanbour, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Massachusetts General Physicians Organization Inc
Boston, MA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - Massachusetts BORIM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 - they are NOT specific to Sarah Kanbour, M.D.. To verify Sarah Kanbour, M.D.'s current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Sarah Kanbour, M.D. - brand share 95.0%
Endocrinology, Diabetes & Metabolism Physician average
95% brand-name claims vs 0% generic, on 20 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
20
Total Claims
$12K
Total Drug Cost
12
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 28.267
- Total Day Supply
- 825
- Brand vs Generic
- 95% brand / 0% generic
- Brand Drug Cost
- $12K
Patient Demographics
- Average Patient Age
- 71.7 years
- Avg HCC Risk Score
- 2.76
More Endocrinology, Diabetes & Metabolism Physician in MA →
All providers in Massachusetts →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Sarah Kanbour, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
8,078
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,739
Avg Claims per Provider
Sarah Kanbour, M.D.'s 20 claims are below the specialty average of 2,739.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Kanbour, both outside Massachusetts so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2017)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as Kanbour.
One of 373 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Massachusetts, 5 are shown here.
Dr. Alice Abbott
MD
Leeds, MA
Dr. Adham Abdel Mottalib
MD
Boston, MA
Dr. Martin Abrahamson
M.D.
Boston, MA
Dr. Ana Paula Abreu Metzger
M.D., PHD
Boston, MA
Gail Adler
MD PHD
Boston, MA
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Sarah Kanbour, M.D.'s specialty? ▼
Sarah Kanbour, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Boston, Massachusetts. Credentials: M.D..
How much does Sarah Kanbour, M.D. prescribe under Medicare Part D? ▼
In 2024, Sarah Kanbour, M.D. wrote 20 Medicare Part D claims totaling $12K in drug costs for 12 beneficiaries.
Where is Sarah Kanbour, M.D. located? ▼
Sarah Kanbour, M.D. is located at 55 FRUIT STREET, Boston, MA, 02114. Phone: (617) 726-8722.
What is Sarah Kanbour, M.D.'s NPI number? ▼
Sarah Kanbour, M.D.'s National Provider Identifier (NPI) is 1205364502, issued on 05/31/2017.
Does Sarah Kanbour, M.D. prescribe more brand-name or generic drugs? ▼
Sarah Kanbour, M.D.'s prescribing is 95% brand-name and 0% generic drugs by claim count, with $12K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 8,078 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,739 Medicare Part D claims per year.
Does Sarah Kanbour, M.D. accept Medicare? ▼
Sarah Kanbour, M.D. appears in CMS Medicare data with 20 Part D claims and 12 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Sarah Kanbour, M.D.'s credentials? ▼
Sarah Kanbour, M.D.'s NPI is 1205364502 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.